Picture of Nevro logo

NVRO Nevro Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual cashflow statement for Nevro, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-104-83.1-1313-92.2
Depreciation
Amortisation
Non-Cash Items51.868.768.764.466
Unusual Items
Other Non-Cash Items
Changes in Working Capital-2.8910.815.8-48.9-39.7
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-50.21.19-41.924.7-58.8
Capital Expenditures-3.47-6.03-12.3-7.54-8.59
Purchase of Fixed Assets
Other Investing Cash Flow Items35.8-36421471.81.39
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities32.3-37020264.3-7.2
Financing Cash Flow Items-3.06-14.7-8.06-8.85-10.6
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities32.1347-169-2.4649.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash14.5-21.1-9.8985.7-16.2